Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1
Purpose To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Methods Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study....
Saved in:
| Published in | Japanese journal of ophthalmology Vol. 58; no. 2; pp. 172 - 176 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Tokyo
Springer Japan
01.03.2014
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0021-5155 1613-2246 1613-2246 |
| DOI | 10.1007/s10384-014-0308-6 |
Cover
| Abstract | Purpose
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls.
Methods
Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups.
Results
The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (
p
< 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm
3
) than in the healthy controls (7.19 ± 0.36 mm
3
;
p
= 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm
3
;
p
= 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA.
Conclusion
The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients. |
|---|---|
| AbstractList | Purpose
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls.
Methods
Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups.
Results
The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (
p
< 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm
3
) than in the healthy controls (7.19 ± 0.36 mm
3
;
p
= 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm
3
;
p
= 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA.
Conclusion
The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients. Purpose: To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Methods: Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. Results: The average RNFL thickness was significantly lower in the OPG group (76.72 plus or minus 22.16 mu m) than in the controls (108.89 plus or minus 9.92 mu m) and NF-1 patients without OPGs (111.17 plus or minus 12.13 mu m) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 plus or minus 0.66 mm super(3)) than in the healthy controls (7.19 plus or minus 0.36 mm super(3); p = 0.001) and NF-1 patients without OPGs (7.25 plus or minus 0.26 mm super(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. Conclusion: The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients. To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm(3)) than in the healthy controls (7.19 ± 0.36 mm(3); p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients. To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls.PURPOSETo compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls.Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups.METHODSTen patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups.The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm(3)) than in the healthy controls (7.19 ± 0.36 mm(3); p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA.RESULTSThe average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm(3)) than in the healthy controls (7.19 ± 0.36 mm(3); p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA.The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.CONCLUSIONThe results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients. To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 [mu]m) than in the controls (108.89 ± 9.92 [mu]m) and NF-1 patients without OPGs (111.17 ± 12.13 [mu]m) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm^sup 3^) than in the healthy controls (7.19 ± 0.36 mm^sup 3^; p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm^sup 3^; p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.[PUBLICATION ABSTRACT] |
| Author | Kasim, Burcu Kiratli, Hayyam Topcu-Yilmaz, Pinar |
| Author_xml | – sequence: 1 givenname: Pinar surname: Topcu-Yilmaz fullname: Topcu-Yilmaz, Pinar organization: Department of Ophthalmology, Konya Training and Research Hospital – sequence: 2 givenname: Burcu surname: Kasim fullname: Kasim, Burcu organization: Department of Ophthalmology, Hacettepe University School of Medicine – sequence: 3 givenname: Hayyam surname: Kiratli fullname: Kiratli, Hayyam email: hkiratli@hacettepe.edu.tr organization: Department of Ophthalmology, Hacettepe University School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24488155$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUFvFSEQx4mpsa-tH8CL2cRLL6vMAMvu0TRamzTpRQ89EZY321L3wRPYmn57aV81pommByCZ_H4MzP-A7YUYiLE3wN8D5_pDBi562XKoS_C-7V6wFXQgWkTZ7bEV5witAqX22UHON5xziQJfsX2Usu9rfcUuz8It5eKvbPExNHFqEhUf7NwESrfUTH6k1Mz2ru7l2rvvgXJufGi2VaBQcvPTl-sKLylWNsWNLTH73MIReznZOdPrx_OQffv86evJl_b84vTs5ON56yQOpRXr0WnsHAfnpFW8tzCSRhwV9hNf2zUp0iBqBaSybpisUCBwUqhRg0VxyI53925T_LHUv5iNz47m2QaKSzagpBiGbuDPQbnWg-yFqui7J-hNXFKdywPVaUDoRaXePlLLuKG12Sa_senO_J5vBWAHuBRzTjT9QYCb-wzNLkNTMzT3GZquOvqJ43x5iKck6-f_mrgzc-0Srij99eh_Sr8AFRGuZw |
| CitedBy_id | crossref_primary_10_1111_aos_14755 crossref_primary_10_1080_02713683_2017_1408130 crossref_primary_10_1080_01658107_2023_2276189 crossref_primary_10_1007_s00381_017_3578_8 crossref_primary_10_1016_j_jfo_2021_08_012 crossref_primary_10_1371_journal_pone_0305548 crossref_primary_10_1038_s41598_024_71832_2 crossref_primary_10_1097_IAE_0000000000000650 crossref_primary_10_1097_WNO_0000000000001241 crossref_primary_10_1007_s00417_018_4007_8 crossref_primary_10_1016_j_survophthal_2017_10_007 crossref_primary_10_1080_13816810_2023_2245464 crossref_primary_10_1007_s10792_016_0412_3 crossref_primary_10_1080_13816810_2020_1849315 crossref_primary_10_3389_fneur_2018_01102 |
| Cites_doi | 10.1093/neuonc/nos076 10.1001/archopht.119.4.516 10.1002/ana.410410204 10.1097/WNO.0b013e31822aef82 10.1016/S1474-4422(06)70573-7 10.1016/S0022-3476(95)70159-1 10.1016/S0002-9394(00)00852-7 10.1097/ICU.0b013e3283313d4e 10.1167/iovs.06-0327 10.1016/S0887-8994(00)00230-7 10.1167/iovs.07-1127 10.1016/j.jaapos.2010.08.014 10.1002/ana.21107 10.1055/s-2008-1073043 10.1111/j.1444-0938.2007.00151.x 10.1016/j.ajo.2010.08.046 10.1016/j.jaapos.2006.02.004 10.1016/0887-8994(94)00110-N 10.1111/j.1442-9071.2009.02015.x 10.1016/j.ophtha.2005.10.040 10.1016/S0022-3476(94)70122-9 10.1016/0887-8994(95)90005-5 |
| ContentType | Journal Article |
| Copyright | Japanese Ophthalmological Society 2014 |
| Copyright_xml | – notice: Japanese Ophthalmological Society 2014 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7T7 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. M0S M1P M7N P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7TK |
| DOI | 10.1007/s10384-014-0308-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitleList | Neurosciences Abstracts MEDLINE MEDLINE - Academic Technology Research Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1613-2246 |
| EndPage | 176 |
| ExternalDocumentID | 3244483451 24488155 10_1007_s10384_014_0308_6 |
| Genre | Journal Article Comparative Study Observational Study |
| GroupedDBID | --- --K -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 1B1 1N0 1~5 203 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 4G. 53G 5GY 5VS 67Z 6NX 7-5 7.U 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAEDT AAHNG AAIAL AAJBT AAJKR AALRI AANXM AANZL AAQFI AAQXK AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAXUO AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABWVN ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACIUM ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPIV ACPRK ACRPL ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMUD ADNMO ADPHR ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FDB FEDTE FERAY FFXSO FGOYB FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HLICF HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LLZTM M1P M41 M4Y MA- N2Q NB0 NPVJJ NQ- NQJWS NU0 O9- O93 O9I O9J OAM P2P P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R2- R89 R9I RIG ROL RPX RPZ RRX RSV S16 S1Z S27 S37 S3B SAP SDH SDM SEW SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD SSZ STPWE SV3 SZ9 SZN T13 TKC TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7J X7M YLTOR Z45 Z7U Z87 ZGI ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEUPX AEZWR AFDZB AFHIU AFOHR AFPUW AGQPQ AHPBZ AHWEU AIXLP ATHPR CITATION PHGZM PHGZT PJZUB PPXIY PUEGO CGR CUY CVF ECM EIF NPM 7QL 7T7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS 7X8 7TK |
| ID | FETCH-LOGICAL-c429t-3dbc726c01cc4a508a1be722b528f0dade5e713722145ac9fa35132f527271a23 |
| IEDL.DBID | U2A |
| ISSN | 0021-5155 1613-2246 |
| IngestDate | Thu Oct 02 10:22:29 EDT 2025 Wed Oct 01 12:43:49 EDT 2025 Fri Oct 03 09:21:58 EDT 2025 Thu Apr 03 07:01:04 EDT 2025 Wed Oct 01 04:37:12 EDT 2025 Thu Apr 24 23:08:16 EDT 2025 Fri Feb 21 02:35:03 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Optic pathway glioma Optical coherence tomography Retinal nerve fiber layer thickness Neurofibromatosis-1 |
| Language | English |
| License | http://www.springer.com/tdm |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c429t-3dbc726c01cc4a508a1be722b528f0dade5e713722145ac9fa35132f527271a23 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Undefined-3 |
| PMID | 24488155 |
| PQID | 1506712183 |
| PQPubID | 34516 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_1543996902 proquest_miscellaneous_1507794835 proquest_journals_1506712183 pubmed_primary_24488155 crossref_primary_10_1007_s10384_014_0308_6 crossref_citationtrail_10_1007_s10384_014_0308_6 springer_journals_10_1007_s10384_014_0308_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-03-01 |
| PublicationDateYYYYMMDD | 2014-03-01 |
| PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Tokyo |
| PublicationPlace_xml | – name: Tokyo – name: Japan |
| PublicationSubtitle | The Official English-Language Journal of the Japanese Ophthalmological Society |
| PublicationTitle | Japanese journal of ophthalmology |
| PublicationTitleAbbrev | Jpn J Ophthalmol |
| PublicationTitleAlternate | Jpn J Ophthalmol |
| PublicationYear | 2014 |
| Publisher | Springer Japan Springer Nature B.V |
| Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
| References | Wolsey, Larson, Creel, Hoffman (CR17) 2006; 10 Subei, Eggenberger (CR11) 2009; 20 Avery, Liu, Fisher, Quinn, Belasco, Phillips (CR12) 2011; 151 Balcer, Liu, Heller, Bilaniuk, Volpe, Galetta (CR6) 2001; 131 Danesh-Meyer, Carroll, Foroozan, Savino, Fan, Jiang (CR19) 2006; 47 Sakata, Deleon-Ortega, Sakata, Girkin (CR10) 2009; 37 Listernick, Louis, Packer, Gutmann (CR8) 1997; 41 Listernick, Charrow, Greenwald, Mets (CR3) 1994; 125 Frohman, Costello, Zivadinov, Stuve, Conger, Winslow (CR22) 2006; 5 Parsa, Hoyt, Lesser, Weinstein, Strother, Muci-Mendoza (CR7) 2001; 119 Chen, Lee (CR9) 2007; 90 Liu, Malloy, Needle, Phillips (CR18) 1995; 12 Fisher, Jacobs, Markowitz, Galetta, Volpe, Nano-Schiavi (CR21) 2006; 113 Augsburger, Bolling, Yanoff, Duker (CR1) 2004 Listernick, Ferner, Liu, Gutmann (CR2) 2007; 61 Fisher, Loguidice, Gutmann, Listernick, Ferner, Ullrich (CR15) 2012; 14 Danesh-Meyer, Papchenko, Savino, Law, Evans, Gamble (CR20) 2008; 49 Avery, Fisher, Liu (CR14) 2011; 31 Kuenzle, Weissert, Roulet, Bode, Schefer, Huisman (CR4) 1994; 25 Chang, El-Dairi, Frempong, Burner, Bhatti, Young (CR13) 2010; 14 Listernick, Darling, Greenwald, Strauss, Charrow (CR5) 1995; 127 Ng, North (CR16) 2001; 24 R Listernick (308_CR3) 1994; 125 GT Liu (308_CR18) 1995; 12 BC Kuenzle (308_CR4) 1994; 25 HV Danesh-Meyer (308_CR20) 2008; 49 R Listernick (308_CR5) 1995; 127 LM Sakata (308_CR10) 2009; 37 YT Ng (308_CR16) 2001; 24 DH Wolsey (308_CR17) 2006; 10 CF Parsa (308_CR7) 2001; 119 E Frohman (308_CR22) 2006; 5 AM Subei (308_CR11) 2009; 20 R Listernick (308_CR2) 2007; 61 RA Avery (308_CR14) 2011; 31 JJ Augsburger (308_CR1) 2004 HV Danesh-Meyer (308_CR19) 2006; 47 L Chang (308_CR13) 2010; 14 R Listernick (308_CR8) 1997; 41 RA Avery (308_CR12) 2011; 151 MJ Fisher (308_CR15) 2012; 14 JB Fisher (308_CR21) 2006; 113 LJ Balcer (308_CR6) 2001; 131 J Chen (308_CR9) 2007; 90 17697178 - Clin Exp Optom. 2007 Sep;90(5):317-35 11292406 - Am J Ophthalmol. 2001 Apr;131(4):442-5 7770126 - Neuropediatrics. 1994 Dec;25(6):295-300 21857190 - J Neuroophthalmol. 2011 Sep;31(3):269-78 17065494 - Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4827-35 19696668 - Curr Opin Ophthalmol. 2009 Nov;20(6):462-6 19338607 - Clin Exp Ophthalmol. 2009 Jan;37(1):90-9 7748370 - Pediatr Neurol. 1995 Jan;12(1):89-90 22474213 - Neuro Oncol. 2012 Jun;14(6):790-7 16406539 - Ophthalmology. 2006 Feb;113(2):324-32 7472822 - J Pediatr. 1995 Nov;127(5):718-22 16987732 - Lancet Neurol. 2006 Oct;5(10):853-63 16935228 - J AAPOS. 2006 Aug;10(4):307-11 21168074 - J AAPOS. 2010 Dec;14(6):511-7 11182280 - Pediatr Neurol. 2001 Jan;24(1):44-8 17387725 - Ann Neurol. 2007 Mar;61(3):189-98 21232732 - Am J Ophthalmol. 2011 Mar;151(3):542-9.e2 8021787 - J Pediatr. 1994 Jul;125(1):63-6 9029062 - Ann Neurol. 1997 Feb;41(2):143-9 11296017 - Arch Ophthalmol. 2001 Apr;119(4):516-29 18263812 - Invest Ophthalmol Vis Sci. 2008 May;49(5):1879-85 |
| References_xml | – volume: 14 start-page: 790 year: 2012 end-page: 797 ident: CR15 article-title: Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis publication-title: Neuro Oncol doi: 10.1093/neuonc/nos076 – start-page: 1097 year: 2004 ident: CR1 article-title: Phakomatoses publication-title: Ophthalmology – volume: 119 start-page: 516 year: 2001 end-page: 529 ident: CR7 article-title: Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging publication-title: Arch Ophthalmol doi: 10.1001/archopht.119.4.516 – volume: 41 start-page: 143 year: 1997 end-page: 149 ident: CR8 article-title: Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force publication-title: Ann Neurol doi: 10.1002/ana.410410204 – volume: 31 start-page: 269 year: 2011 end-page: 278 ident: CR14 article-title: Optic pathway gliomas publication-title: J Neuro-ophthalmol doi: 10.1097/WNO.0b013e31822aef82 – volume: 5 start-page: 853 year: 2006 end-page: 863 ident: CR22 article-title: Optical coherence tomography in multiple sclerosis publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70573-7 – volume: 127 start-page: 718 year: 1995 end-page: 722 ident: CR5 article-title: Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history publication-title: J Pediatr doi: 10.1016/S0022-3476(95)70159-1 – volume: 131 start-page: 442 year: 2001 end-page: 445 ident: CR6 article-title: Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(00)00852-7 – volume: 20 start-page: 462 year: 2009 end-page: 466 ident: CR11 article-title: Optical coherence tomography: another useful tool in a neuro-ophthalmologist’s armamentarium publication-title: Curr Opin Ophthalmol doi: 10.1097/ICU.0b013e3283313d4e – volume: 47 start-page: 4827 year: 2006 end-page: 4835 ident: CR19 article-title: Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.06-0327 – volume: 24 start-page: 44 year: 2001 end-page: 48 ident: CR16 article-title: Visual-evoked potentials in the assessment of optic gliomas publication-title: Pediatr Neurol doi: 10.1016/S0887-8994(00)00230-7 – volume: 49 start-page: 1879 year: 2008 end-page: 1885 ident: CR20 article-title: In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for postchiasmal tumors publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-1127 – volume: 14 start-page: 511 year: 2010 end-page: 517 ident: CR13 article-title: Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas publication-title: J AAPOS doi: 10.1016/j.jaapos.2010.08.014 – volume: 61 start-page: 189 year: 2007 end-page: 198 ident: CR2 article-title: Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations publication-title: Ann Neurol doi: 10.1002/ana.21107 – volume: 25 start-page: 295 year: 1994 end-page: 300 ident: CR4 article-title: Follow-up of optic pathway gliomas in children with neurofibromatosis type 1 publication-title: Neuropediatrics doi: 10.1055/s-2008-1073043 – volume: 90 start-page: 317 year: 2007 end-page: 335 ident: CR9 article-title: Clinical applications and new developments of optical coherence tomography: an evidence-based review publication-title: Clin Exp Optom doi: 10.1111/j.1444-0938.2007.00151.x – volume: 151 start-page: 542 year: 2011 end-page: 549 ident: CR12 article-title: Retinal nerve fiber layer thickness in children with optic pathway gliomas publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2010.08.046 – volume: 10 start-page: 307 year: 2006 end-page: 311 ident: CR17 article-title: Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? publication-title: J AAPOS doi: 10.1016/j.jaapos.2006.02.004 – volume: 12 start-page: 89 year: 1995 end-page: 90 ident: CR18 article-title: Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials publication-title: Pediatr Neurol doi: 10.1016/0887-8994(94)00110-N – volume: 37 start-page: 90 year: 2009 end-page: 99 ident: CR10 article-title: Optical coherence tomography of the retina and optic nerve—a review publication-title: Clin Exp Ophthalmol doi: 10.1111/j.1442-9071.2009.02015.x – volume: 113 start-page: 324 year: 2006 end-page: 332 ident: CR21 article-title: Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.10.040 – volume: 125 start-page: 63 year: 1994 end-page: 66 ident: CR3 article-title: Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study publication-title: J Pediatr doi: 10.1016/S0022-3476(94)70122-9 – volume: 31 start-page: 269 year: 2011 ident: 308_CR14 publication-title: J Neuro-ophthalmol doi: 10.1097/WNO.0b013e31822aef82 – volume: 151 start-page: 542 year: 2011 ident: 308_CR12 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2010.08.046 – volume: 5 start-page: 853 year: 2006 ident: 308_CR22 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70573-7 – volume: 131 start-page: 442 year: 2001 ident: 308_CR6 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(00)00852-7 – volume: 14 start-page: 511 year: 2010 ident: 308_CR13 publication-title: J AAPOS doi: 10.1016/j.jaapos.2010.08.014 – volume: 90 start-page: 317 year: 2007 ident: 308_CR9 publication-title: Clin Exp Optom doi: 10.1111/j.1444-0938.2007.00151.x – volume: 20 start-page: 462 year: 2009 ident: 308_CR11 publication-title: Curr Opin Ophthalmol doi: 10.1097/ICU.0b013e3283313d4e – volume: 113 start-page: 324 year: 2006 ident: 308_CR21 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.10.040 – volume: 127 start-page: 718 year: 1995 ident: 308_CR5 publication-title: J Pediatr doi: 10.1016/S0022-3476(95)70159-1 – volume: 24 start-page: 44 year: 2001 ident: 308_CR16 publication-title: Pediatr Neurol doi: 10.1016/S0887-8994(00)00230-7 – volume: 10 start-page: 307 year: 2006 ident: 308_CR17 publication-title: J AAPOS doi: 10.1016/j.jaapos.2006.02.004 – volume: 61 start-page: 189 year: 2007 ident: 308_CR2 publication-title: Ann Neurol doi: 10.1002/ana.21107 – volume: 25 start-page: 295 year: 1994 ident: 308_CR4 publication-title: Neuropediatrics doi: 10.1055/s-2008-1073043 – volume: 119 start-page: 516 year: 2001 ident: 308_CR7 publication-title: Arch Ophthalmol doi: 10.1001/archopht.119.4.516 – volume: 47 start-page: 4827 year: 2006 ident: 308_CR19 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.06-0327 – start-page: 1097 volume-title: Ophthalmology year: 2004 ident: 308_CR1 – volume: 14 start-page: 790 year: 2012 ident: 308_CR15 publication-title: Neuro Oncol doi: 10.1093/neuonc/nos076 – volume: 41 start-page: 143 year: 1997 ident: 308_CR8 publication-title: Ann Neurol doi: 10.1002/ana.410410204 – volume: 49 start-page: 1879 year: 2008 ident: 308_CR20 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-1127 – volume: 125 start-page: 63 year: 1994 ident: 308_CR3 publication-title: J Pediatr doi: 10.1016/S0022-3476(94)70122-9 – volume: 12 start-page: 89 year: 1995 ident: 308_CR18 publication-title: Pediatr Neurol doi: 10.1016/0887-8994(95)90005-5 – volume: 37 start-page: 90 year: 2009 ident: 308_CR10 publication-title: Clin Exp Ophthalmol doi: 10.1111/j.1442-9071.2009.02015.x – reference: 17697178 - Clin Exp Optom. 2007 Sep;90(5):317-35 – reference: 17065494 - Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4827-35 – reference: 17387725 - Ann Neurol. 2007 Mar;61(3):189-98 – reference: 19338607 - Clin Exp Ophthalmol. 2009 Jan;37(1):90-9 – reference: 8021787 - J Pediatr. 1994 Jul;125(1):63-6 – reference: 21232732 - Am J Ophthalmol. 2011 Mar;151(3):542-9.e2 – reference: 16935228 - J AAPOS. 2006 Aug;10(4):307-11 – reference: 19696668 - Curr Opin Ophthalmol. 2009 Nov;20(6):462-6 – reference: 16987732 - Lancet Neurol. 2006 Oct;5(10):853-63 – reference: 11182280 - Pediatr Neurol. 2001 Jan;24(1):44-8 – reference: 21857190 - J Neuroophthalmol. 2011 Sep;31(3):269-78 – reference: 22474213 - Neuro Oncol. 2012 Jun;14(6):790-7 – reference: 21168074 - J AAPOS. 2010 Dec;14(6):511-7 – reference: 7770126 - Neuropediatrics. 1994 Dec;25(6):295-300 – reference: 11292406 - Am J Ophthalmol. 2001 Apr;131(4):442-5 – reference: 7748370 - Pediatr Neurol. 1995 Jan;12(1):89-90 – reference: 7472822 - J Pediatr. 1995 Nov;127(5):718-22 – reference: 11296017 - Arch Ophthalmol. 2001 Apr;119(4):516-29 – reference: 16406539 - Ophthalmology. 2006 Feb;113(2):324-32 – reference: 18263812 - Invest Ophthalmol Vis Sci. 2008 May;49(5):1879-85 – reference: 9029062 - Ann Neurol. 1997 Feb;41(2):143-9 |
| SSID | ssj0004232 |
| Score | 2.10118 |
| Snippet | Purpose
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of... To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy... Purpose: To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 172 |
| SubjectTerms | Adolescent Child Clinical Investigation Female Humans Magnetic Resonance Imaging Male Medicine Medicine & Public Health Nerve Fibers - pathology Neurofibromatosis 1 - diagnosis Ophthalmology Optic Nerve Glioma - diagnosis Prospective Studies Retina - pathology Retinal Ganglion Cells - pathology Tomography, Optical Coherence Vision Disorders - diagnosis Visual Acuity Visual Fields |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS9xAEB7sCaUvRW2taVVW6FPLYrLJbvYeRFQUETxEFOxT2OwPECVR7_z_O5Ns7izSe8hLsgvDzuzMt5nZbwB-EiRQKhhuChF4IZzntdOBW6OUKIImAiKqtpio89vi4k7ercBkuAtDZZWDT-wctWst_SPfJya8MqOAfvj0zKlrFGVXhxYaJrZWcAcdxdgHWBXEjDWC1ePTydX14qakyCN_eMapucmQ5-wv0-WaKjLwyVPN1b-R6h38fJc67SLS2Rp8jlCSHfW6X4cV32zAx8uYLP8Cf95waLQNawOjG4s0paEyRxaoWIQ9GgTdjKreH8jrsfuGRa7VKaOftKxjvMSxLy2C23Z6P-XZV7g9O705OeexkwK3GG9mPHe1LYWyaWZtYRCTmaz2pRC1FDqkzjgvPZ5W8U1WSGPHweQSj6lBCoQ3mRH5JoyatvFbwDzGNReUC0GGQo5F7crSFDp4rcdBmjKBdFi1ykaacep28VgtCJJpoStc6IoWulIJ_JpPeeo5NpYN3h5UUcXtNq0WxpHA3vwzbhTKfpjGt6_dmBKdDyLOZWPoeKbGqUjgW6_muUSIg7RGk0ng96D3NwL8T9zvy8X9AZ9Eb3FoeNswmr28-h1EObN6N5ruXzLu91M priority: 102 providerName: ProQuest |
| Title | Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1 |
| URI | https://link.springer.com/article/10.1007/s10384-014-0308-6 https://www.ncbi.nlm.nih.gov/pubmed/24488155 https://www.proquest.com/docview/1506712183 https://www.proquest.com/docview/1507794835 https://www.proquest.com/docview/1543996902 |
| Volume | 58 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1613-2246 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004232 issn: 0021-5155 databaseCode: AFBBN dateStart: 20040101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1613-2246 dateEnd: 20190131 omitProxy: true ssIdentifier: ssj0004232 issn: 0021-5155 databaseCode: 7X7 dateStart: 20040101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1613-2246 dateEnd: 20190131 omitProxy: true ssIdentifier: ssj0004232 issn: 0021-5155 databaseCode: BENPR dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1613-2246 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004232 issn: 0021-5155 databaseCode: AGYKE dateStart: 20040101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1613-2246 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004232 issn: 0021-5155 databaseCode: U2A dateStart: 20040125 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFspeSrutq_sRVNhTh8CWrY88piVZ2GgZo4Hkyci2BKHFLnX6__fOsZOUboE9GIN9MuLuJP3ku_sJ4BtBAqW85TYRnieicDwrjOe5VUok3hABEWVb3KnxJPk5ldO2jrvust27kGQzU28Uu8WGMibwikPD1Q7sSWLzQieeiMG6GFLELUV4xOn8ki6U-bdPvF2M3iHMd9HRZtEZHcJBixbZYGneI_jgyk-wf9vGwz_DbIMmoypZ5RkVJVKTkjIZmad8EPZoEVczSmx_oImNzUvW0qnWjP7DsobUEmWfK8SvVT2vefQFJqPh_c2Yt4cl8ByXlAWPiyzXQuVhlOeJRdhlo8xpITIpjA8LWzjpcEOKT6JE2rzvbSxxJ-qlQAQTWREfw25Zle4EmMOlq_Cq8F76RPZFVmhtE-OdMX0vrQ4g7LSW5i2TOB1o8ZiuOZBJ0SkqOiVFpyqAq1WTpyWNxjbh884UaTui6pSYEHVEgC6Ay9VrHAsU4LClq14aGY3zC4LKbTK0A1P9UATwdWnmVY8Q6hiDLhPA987uGx34V3dP_0v6DD6KpQOiH57D7uL5xV0grllkPdjRU92DvcGP2a8h3q-Hd7__9BrvfgWWnvFs |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VrQRcEG9CCxgJLiCLxHEc51AhHq22tF0h1ErllDqxLVVUSdtshfhz_DZmEme3qGJvPewl60jWeDzzTWbmG4DXBAmU8oYbKTyXwjpeWe15bZQS0msiIKJqi6maHMqvR9nRCvwZe2GorHK0ib2htm1N38jfExNenpBD_3B2zmlqFGVXxxEaJoxWsJs9xVho7Nh1v39hCNdt7nzB834jxPbWwecJD1MGeI22eMZTW9W5UHWc1LU0iFdMUrlciCoT2sfWWJc5jOTwSSIzUxfepBmGcD4T6PoTQ8QH6ALWZCoLDP7WPm1Nv31fdGaKNPCVJ5yGqYx51aF5L9VUAYK_NNZc_esZr8Hda6na3gNu34O7Abqyj4Ou3YcV1zyAW_shOf8Qflzh7Ggb1npGHZL0SkNllcxTcQo7NQjyGVXZ_yQry04aFrhdO0YfhVnPsIlrL1oE02130vHkERzeiEwfw2rTNu4pMId-1Hplvc-8zApR2Tw3UnundeEzk0cQj1Ir60BrTtM1TssFITMJukRBlyToUkXwdv7K2cDpsWzxxngUZbjeXblQxghezf_Gi0nZFtO49rJfk6OxQ4S7bA2Fg6qIRQRPhmOe7whxl9aoMhG8G8_9ygb-t91ny7f7Em5PDvb3yr2d6e463BGD9qESbsDq7OLSPUeENateBDVmcHzTN-cvKiozdg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT-QwDLZ4SIgLApZdyjMr7QkU0aZJmjkiYMRjF-1hR4JTlTaJhEAtosP_x562w6x4SBx6aZ0qsp3mS21_BvhFkEDrYLmVInApnOeFM4GXVmshgyECIsq2uNbnI3l5o266PqdNn-3ehyTbmgZiaarGR48uHM0UvqWGsifwSmPD9TwsSuJJQIceiePXwkiRdnThCadeJn1Y871X_L8xvUGbbyKlkw1ouAorHXJkx62p12DOV-uw9KeLjX-D2xnKjLpidWBUoEhDKspqZIFyQ9iDRYzNKMn9nj5y7K5iHbVqw-ifLJsQXKLsU41Ytm7uGp5swGh49u_knHeNE3iJ28uYp64oM6HLOClLaRGC2aTwmRCFEibEzjqvPB5O8U4ilS0HwaYKT6VBCUQziRXpd1io6spvAvO4jbmgXQgqSDUQhcsyK03wxgyCslkEca-1vOxYxam5xUP-yodMis5R0TkpOtcRHEyHPLaUGp8J7_SmyLvV1eTEipglBO4i-Dl9jOuCgh228vXzRCbDbw0CzM9k6DSmB7GI4Edr5umMEPYYgy4TwWFv95kJfDTdrS9J78PS39Nh_vvi-moblkXri-iSO7Awfnr2uwh3xsXexKVfADI59H8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Investigation+of+retinal+nerve+fiber+layer+thickness+in+patients+with+neurofibromatosis-1&rft.jtitle=Japanese+journal+of+ophthalmology&rft.au=Topcu-Yilmaz%2C+Pinar&rft.au=Kasim%2C+Burcu&rft.au=Kiratli%2C+Hayyam&rft.date=2014-03-01&rft.pub=Springer+Japan&rft.issn=0021-5155&rft.eissn=1613-2246&rft.volume=58&rft.issue=2&rft.spage=172&rft.epage=176&rft_id=info:doi/10.1007%2Fs10384-014-0308-6&rft.externalDocID=10_1007_s10384_014_0308_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5155&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5155&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5155&client=summon |